Skip to main navigation Skip to search Skip to main content

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

  • Jesus G. Berdeja
  • , Deepu Madduri
  • , Saad Z. Usmani
  • , Andrzej Jakubowiak
  • , Mounzer Agha
  • , Adam D. Cohen
  • , A. Keith Stewart
  • , Parameswaran Hari
  • , Myo Htut
  • , Alexander Lesokhin
  • , Abhinav Deol
  • , Nikhil C. Munshi
  • , Elizabeth O'Donnell
  • , David Avigan
  • , Indrajeet Singh
  • , Enrique Zudaire
  • , Tzu Min Yeh
  • , Alicia J. Allred
  • , Yunsi Olyslager
  • , Arnob Banerjee
    • Carolyn C. Jackson, Jenna D. Goldberg, Jordan M. Schecter, William Deraedt, Sen Hong Zhuang, Jeffrey Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin, Thomas Martin, Sundar Jagannath

Research output: Contribution to journal › Article › peer-review

1543   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Immunology and Microbiology